• Join
  • Login
  • Contact

Search abstracts / presentations

Bioequivalence study of oseltamivir phosphate capsules

  • In: SIG Bioavailability/Bioequivalence - Posters
  • At: Beijing (China) (2007)
  • Type: Poster
  • Poster code: BB-P-035
  • By: CHEN, Xiaoyan (Institute of Materia Medica, Shanghai, China)
  • Co-author(s): Dai, Xiaojian (Institute of Materia Medica, SHANGHAI, China)
    Zhong, Dafang (Institute of Materia Medica, SHANGHAI, China)
    Chen, Wangsheng (Shanghai Changzheng Hospital, SHANGHAI, China)
  • Abstract:

    OBJECTIVE A study was conducted to establish the bioequivalence between a newly developed Oseltamivir Phosphate Capsules (as the test formulation, Shanghai Sunve Pharmaceutical Co., Ltd, China) and TamifluÂ[RSYMBOL] (as the reference formulation, Roche, Switzerland). METHODS The clinical investigation was designed as a randomized, open-labelled ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses